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Abstract 
Rat and human steroidogenic organs contain an enzyme activity that is indistinguishable from hepatic lipase present in liver. 
Using primers that recognize xons 5 and 8 of the rat and human HL gene, a 596-bp product was found by RT-PCR in rat liver, 
adrenal, ovaries and testes, but not in heart and kidney. A similar product was also observed with human hyperplastic 
adrenocortical tissue. Identity of this product with part of the HL cDNA was confirmed by restriction mapping and internal 
re-amplification. Our results indicate that the HL gene is transcribed in steroidogenic tissues that also contain I-IL protein. 
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Hepatic lipase (HL, EC 3.1.1.34) is present in the 
liver of most vertebrates at the endothelial lining of 
blood sinusoids [l]. The enzyme plays a central role in 
lipoprotein metabolism. Notably, HL is shown to facili- 
tate uptake by liver cells of cholesterol from high-den- 
sity lipoproteins (HDL) [l-3]. A highly similar enzyme 
activity (liver-type lipase) has been detected in rat, 
human, hamster and bovine adrenal cortex [4-61 and in 
rat ovaries [5,7J At least in the rat, these organs 
depend largely on HDL cholesterol as the source for 
steroidogenesis [8,9]. Immunologically and kinetically, 
the liver-type lipases are indistinguishable from HL 
present in liver [lO,ll]. In addition, the adrenal lipase 
has a peptide map which is similar to that of hepatic 
lipase from liver [12]. These observations strongly sug- 
gest that these lipases represent a single gene product. 
The origin of the liver-type lipases in the steroido- 
genie organs remains unknown. Attempts to detect 
local de novo synthesis in unstimulated rat adrenals 
and highly luteinized ovaries have been unsuccessful 
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[12,13]. HL mRNA has never been observed in adrenals 
and ovaries by classical Northern blotting [12-151, nor 
in ovaries by application of the polymerase chain reac- 
tion [13]. This led to the hypothesis that the liver-type 
lipases are synthesized exclusively in the liver, and are 
subsequently transported to and sequestered in the 
steroidogenic organs. In normal rat and human plasma, 
however, hepatic lipase is hardly detectable [16]. We 
therefore decided to reinvestigate the possibility of 
local synthesis, by studying the expression of HL mRNA 
in steroidogenic organs by RT-PCR. 
Total RNA was isolated by the method of Chom- 
czynski and Sacchi [17]. Adrenals, testes, liver, heart 
and kidney were rapidly dissected from male Wistar 
rats (250-300 g). Ovaries were obtained from imma- 
ture rats treated for various times with the go- 
nadotrophins PMS and HCG [18]. Human hyperplastic 
adrenals were obtained from two patients suffering 
from Cushing’s disease who were subjected to bilateral 
adrenalectomy. Total RNA was also isolated from the 
human hepatoma cell line HepG2 and umbilical vein 
endothelial cells (passage 51, starting from one T150 
flask (Nunc, Roskilde, Denmark) of confluent cells 
each. RNA concentrations were determined by spec- 
trophotometry at 260 nm [19]. The quality of all RNA 
preparations was similar as judged from the pattern of 
ribosomal RNA after gel-electrophoresis [19]. 
RT-PCR was performed in a single tube, using the 
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RNA-PCR kit from Perkin Elmer Cetus. Routinely, I 
pug of total RNA was reverse-transcribed using 
oligo(dT),,. Amplification was performed in 35 cycles 
of, successively, 1 min 95°C 1 min 55 “C and 1 mm 
72”C, using the oligonucleotides I-&l (5’-GTG GGC 
ATC A4A CAG CCC3’, nt 697-714) and HL2 (5’- 
CAG ACA TTG GCC CAC ACT G-3’, nt 1292-1274; 
numbering according to the rat cDNA sequence, see 
Ref. 14) as forward and reverse primers, respectively. 
These oligonucleotides recognize both the rat and hu- 
man HL sequence in exon 5 and 8, respectively [14,20- 
231. Possible contamination with DNA was assessed in 
parallel incubations in which reverse transcriptase was 
omitted. A no-template control was included in each 
experiment. PCR products were analyzed by elec- 
trophoresis in a 3% agarose gel (Nusieve: Seakem = 3:l; 
FMC Bioproducts, Vallensbaek Strand, Denmark). 
For re-amplification, the PCR mixture was diluted 
lOOOO-fold into a fresh one, and PCR was performed 
for 25 cycles using the primers HL-2 and HL3 (5’-CGG 
GGG CTC CTT CCA GCC TGG-3’, nt 741-761). For 
restriction enzyme analysis, 15 pl-aliquots were diluted 
into 100 ,ul of the appropriate buffer; after overnight 
digestion, the DNA was collected by ethanol precipita- 
tion. Restriction enzymes and DNA molecular weight 
markers were from Boehringer-Marmheim, Germany. 
Lipase activity assays, immunoinhibition assays and 
chromatography on Sepharose-heparin were per- 
formed as described previously [4,10]. Protein was de- 
termined by the Lowry assay [24] using bovine serum 
albumin as a standard. 
RT-PCR on total RNA isolated from rat liver yielded 
one major product with the expected size of 596-bp 
(Fig. 1A). Using the same conditions, a similarly sized 
product was generated with RNA prepared from whole 
adrenals. This result was not due to contamination 
with DNA, as amplification of the 596-bp product was 
not seen in the absence of reverse transcriptase (-RT 
control). In contrast, RT-PCR on heart and kidney 
RNA using I&specific oligonucleotides remained neg- 
ative (Fig. lA), although all RNA preparations were of 
similar quality and readily allowed for the amplifica- 
tion of full-length mRNA for glyceraldehyde 3-phos- 
phate dehydrogenase (not shown). A 596-bp product 
was also generated with total RNA from stimulated rat 
ovaries and testes (Fig. 1B). 
Identity of the 596-bp PCR products obtained from 
adrenal and ovarian RNA with part of the HL cDNA 
was confirmed by restriction mapping and internal 
re-amplification. Digestion of the products from 
adrenals, ovaries and liver with BcZI and P&I resulted 
in the predicted fragments of 545-bp, and of 400 and 
196-bp, respectively (Fig. 2A and B). An identical 
pattern was also obtained upon partial digestion with 
Suu3A, besides the expected products of complete 
digestion, three extra bands of 377, 249 and 219-bp 
RT 
686- 
A. 
Fig. 1. Detection of HL mRNA in rat adrenals (A), ovaries and 
testes (B). RT-PCR was performed with 1 ng of liver RNA (la&L), 
or with 1 pg of total RNA isolated from two independent adrenal 
preparations (Al and’A2), heart @D and kidney (K), shown in Fig. 
LA, from testes (T) as well as ovaries from rats that had been treated 
for 2 days with PMS followed by 0 (011, 2 (02) or 7 (03) days with 
HCG as previously described {181i shown in Fig. 1B. In Pi. lA, the 
minus RT controls (-1, in which reverse transcriptase was omitted 
from the reaction mixture, are also shown. The no-template controls 
are run in lanes w. The marker lane (Ml contains DNA size markers. 
of 2176, 1766, 1230, 1033, 653, 517, 453, 394, 298, 234, 220 and 154 
bp. Note that the PCR products seen in the kidney lane (Fig. 1AI 
could not be re-amplified with internal primers, indicatfng that they 
are distinct from HL cDNA (not shown). 
were apparent, all agreeing to the restriction map of 
this part of HL cDNA. Furthermore, re-amplification 
of the 596-bp DNA from adrenals, ovaries and liver 
with HL-2 and the internal primer I-IL3 generated a 
product with the predicted size of 552-bp (Fig. 20 
Similar results were obtained with the PCR product- 
from testis RNA (not shown). Taken together, these 
observations indicate that HL mRNA is expressed in 
the rat steroidogenic organs, but not in heart and 
kidney. 
Expression of the mRNA for HL in rat adrenals and 
ovaries, but not in heart and kidney, coincides with the 
presence of a liver-type lipase activity in the former 
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Fig. 2. The 596-bp PCR product is part of the HL cDNA. (A) Partial 
restriction map of the 596-bp PCR product deduced from the cDNA 
sequence for rat I-IL [14]. The restriction sites for BclI, Psi1 and 
Sau3A are indicated as well as the predicted restriction fragment 
lengths. (B) Restriction patterns of the RT-PCR products generated 
from rat liver (L), adrenal (A) and ovarian (0) RNA_ After RT-PCR, 
the reaction mixtures were incubated without any restriction enzyme 
(-), or in the presence of BclI (B) or PstI (PI, and then analyzed by 
agarose gel electrophoresis. Note that in the experiment shown here 
ethidiumbromide staining of the expected 51-bp fragment is too low 
for visualization. The DNA size markers (M) are as defined for Fig. 
1. (C) Internal re-amplification. After RT-PCR of rat liver RNA (L), 
adrenal RNA (A), ovarian RNA (0) and the no-template control 
(w), the reaction mixtures were diluted lo’-fold into a fresh PCR 
mixture. Reampliication was performed either with the original 
primers HL-1 and HG2 (a), or with the combination of HL2 and the 
internal primer HG3 (b). The DNA size markers in lane M are as 
detailed in the legend to Fig. 1. 
organs, but not in the latter. In rat testes, however, HL 
mRNA is present although a similar enzyme activity 
has not been reported previously. In homogenates pre- 
pared from 4 testes, a salt-resistant triglyceridase activ- 
ity was detected, which amounted to 26.8 f0.3 mU/ 
gww (mean f S.D., n = 3). Of this activity, less than 
5% was susceptible to immunoinhibition with poly- 
clonal antibodies against rat liver I-IL. Upon chro- 
matography on Sepharose-heparin, however, a lipase 
activity eluted from the column at the same salt-con- 
centration as HL from rat liver (0.6-0.7 M NaCI), and 
which was 80-90% inhibitable by anti-I& This activity 
amounted to 0.20 & 0.04 mU/gww. Hence, rat testes 
also contain a liver-type lipase activity albeit at much 
lower levels than adrenals and ovaries (40-200 mU/ 
gww). 
Human hyperplastic adrenals have been reported to 
also contain a liver-type lipase activity [4]. We there- 
fore tested whether HL mRNA is expressed in this 
tissue as well. Homogenates prepared from the en- 
larged adrenals of two patients suffering from Cushing’s 
disease contained a salt-resistant lipase activity (Table 
1). On a protein basis, this activity was similar in both 
adrenals of the two patients. A major part of this 
activity was sensitive to immunoinhibition by anti-hu- 
man HL. RT-PCR on the RNA preparations of all four 
adrenals using HLl and HG2 yielded a product of the 
expected 596-bp (Fig. 3). In the absence of reverse 
transcriptase, no product was produced. A similar PCR 
product was also generated with RNA from HepG2 
cells (Fig. 31, which synthesize and secrete HL activity 
into the culture medium, but not with RNA from 
human endothelial cells. Re-amplification of the PCR 
product from HepG2 cells and the adrenals from pa- 
tient 1 using I-!&2 and HL3 resulted in the predicted 
552-bp band (not shown). In addition, treatment of the 
596-bp product from HepG2 cells and human adrenals 
with BcZI gave a highly similar digestion pattern which 
agreed to the restriction map of human HL cDNA (not 
shown). Pst I was inactive with both PCR products as 
this restriction site is absent in human opposed to rat 
HL cDNA [14,20,21]. Hence, I-IL. mRNA and a liver- 
type lipase activity are both present in human hyper- 
plastic adrenals. 
Table 1 
Lipase activities in adrenal glands of patients with Gushing’s disease 
Patient Lipase activity Inhibition by 
(mU/sww) a (mU/mg) b anti-liver lipase 
(o/o) 
1 left 23.4 0.35 
right 22.7 0.26 
2 left 40.8 0.34 
right 45.8 0.40 
’ Activity expressed per tissue wet weight. 
b Activity expressed per mg protein. 
68 
65 
73 
77 
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Fig. 3. Detection of HL mRNA in human adrenal glands by RT-PCR. 
RT-PCR was performed with 1 lug of total RNA prepared from 
HepGZ cells (H), from the left (I) and right (r) adrenal of two 
patients suffering from Gushing’s disease (Al and A2), and from 
human umbilical vein endothelial cells (El. Other symbols are as 
defined in Fig. 1. 
In conclusion, we have shown here that the HL gene 
is transcribed in rat and human steroidogenic organs 
which also express liver-type lipase activity, but not in 
organs and tissues which lack such an activity. This 
finding suggests that the lipase present in these organs 
may be locally produced. Until now, however, neither 
we nor others [12,13] have been able to demonstrate 
HL protein synthesis in these tissues. Although the 
RT-PCR data only allow for qualitative conclusions, 
they seem to indicate that quantitatively expression of 
HL mRNA in the rat tissues is at variance with the 
activity of the liver-type lipase in these organs. First, 
the HL mRNA is readily amplified from testis RNA 
although the activity is at least 2 orders of magnitude 
less than in adrenals and ovaries. Second, quantitation 
by competitive RT-PCR shows that the abundance of 
the HI, mRNA in rat adrenals is 40-fold less than in 
rat liver, although on a wet weight basis both organs 
contain a similar activity (Verhoeven et al., unpub- 
lished data). Therefore, the possibility that the lipase 
activity in the steroidogenic organs originates from the 
liver cannot be excluded. Nevertheless, the simultane- 
ous expression of HL activity and transcription of the 
HL gene exclusively in cholesterol utilizing tissues 
forms an intriguing clue to the function and regulation 
of this enzyme. 
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